Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3923]

Association of BRCA alterations with response to PARP inhibitors in metastatic...

Dr Emmanuel Antonarakis - John Hopkins Sidney Kimmel Comprehensive Cancer...

Association of BRCA alterations with response to PARP inhibitors in metastatic castration-resistant prostate cancer ( Dr Emmanuel Antonarakis - John Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )

LuPSMA vs cabazitaxel in metastatic castration-resistant prostate cancer...

Prof Michael Hofman - Peter MacCallum Cancer Centre, Melbourne, Australia

LuPSMA vs cabazitaxel in metastatic castration-resistant prostate cancer progressing after docetaxel ( Prof Michael Hofman - Peter MacCallum Cancer Centre, Melbourne, Australia )

The paediatric precision oncology study INFORM: Clinical outcome and benefit...

Dr Cornelis van Tilburg - Hopp Children's Cancer Center Heidelberg, Heidelberg...

The paediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups ( Dr Cornelis van Tilburg - Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany )

Maintenance avelumab plus best supportive care (BSC) versus BSC alone after...

Prof Thomas Powles - Barts Cancer Institute, London, UK

Maintenance avelumab plus best supportive care (BSC) versus BSC alone after chemotherapy in advanced urothelial carcinoma ( Prof Thomas Powles - Barts Cancer Institute, London, UK )

Brigatinib for NSCLC, latest research and overcoming complications

Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA

Brigatinib for NSCLC, latest research and overcoming complications ( Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA )

Sym015 shows superior specificity compared to TKIs for NSCLC

Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA

Sym015 shows superior specificity compared to TKIs for NSCLC ( Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA )

CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell...

Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA

CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy for r/r multiple myeloma ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )

Better genetic diagnostics in Ugandan breast cancer patients

Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA

Better genetic diagnostics in Ugandan breast cancer patients ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )

ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer

Prof Roy Herbst - Yale Cancer Center, New Haven, USA

ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer ( Prof Roy Herbst - Yale Cancer Center, New Haven, USA )

Conducting Oncology Clinical Trials in Africa II: AC3T - Assessing, profiling...

Daniel Seymour - BIO Ventures for Global Health, Seattle, USA

Conducting Oncology Clinical Trials in Africa II: AC3T - Assessing, profiling, and building cancer clinical trial capacity in Africa ( Daniel Seymour - BIO Ventures for Global Health, Seattle, USA )

Perioperative use of NSAIDs reduces risk of early relapse in breast cancer

Dr Michael Retsky - Harvard T.H. Chan School of Public Health, Boston, USA

Perioperative use of NSAIDs reduces risk of early relapse in breast cancer ( Dr Michael Retsky - Harvard T.H. Chan School of Public Health, Boston, USA )

Do immune checkpoint inhibitors work in EGFR mutant lung cancer?

Dr Edward Garon - UCLA Medical Center, Santa Monica, USA

Do immune checkpoint inhibitors work in EGFR mutant lung cancer? ( Dr Edward Garon - UCLA Medical Center, Santa Monica, USA )

More from ecancer